DK2056807T3 - Behandling af inflammatoriske sygdomme - Google Patents

Behandling af inflammatoriske sygdomme

Info

Publication number: DK2056807T3
Authority: DK; Denmark
Prior art keywords: treatment; inflammatory diseases; inflammatory; diseases
Prior art date: 2006-08-17

Application number

DK07837041.8T

Other languages

English (en)

Inventor

Betty C Soliven

Original Assignee

Univ Chicago

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2006-08-17

Filing date

2007-08-17

Publication date

2012-10-22

2007-08-17 Application filed by Univ Chicago filed Critical Univ Chicago

2012-10-22 Application granted granted Critical

2012-10-22 Publication of DK2056807T3 publication Critical patent/DK2056807T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/661—Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion or mevinphos
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

DK07837041.8T 2006-08-17 2007-08-17 Behandling af inflammatoriske sygdomme DK2056807T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US83822206P	2006-08-17	2006-08-17
PCT/US2007/018331 WO2008021532A2 (en)	2006-08-17	2007-08-17	Treatment of inflammatory diseases

Publications (1)

Publication Number	Publication Date
DK2056807T3 true DK2056807T3 (da)	2012-10-22

Family

ID=38941849

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK07837041.8T DK2056807T3 (da)	2006-08-17	2007-08-17	Behandling af inflammatoriske sygdomme

Country Status (17)

Country	Link
US (3)	US8258150B2 (da)
EP (2)	EP2392320A1 (da)
JP (3)	JP5216769B2 (da)
CN (2)	CN102526736B (da)
AU (1)	AU2007284337B2 (da)
BR (1)	BRPI0715950A2 (da)
CA (1)	CA2660880C (da)
DK (1)	DK2056807T3 (da)
ES (1)	ES2393631T3 (da)
HK (1)	HK1131047A1 (da)
HR (1)	HRP20121034T1 (da)
MX (1)	MX2009001788A (da)
PL (1)	PL2056807T3 (da)
PT (1)	PT2056807E (da)
RU (1)	RU2440110C2 (da)
SI (1)	SI2056807T1 (da)
WO (1)	WO2008021532A2 (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2414205T3 (es)	2006-06-02	2013-07-18	The Ohio State University Research Foundation	Agentes terapéuticos para el tratamiento de linfoma de células del manto
EP2392320A1 (en) *	2006-08-17	2011-12-07	University Of Chicago	Treatment of inflammatory diseases
US9149459B2 (en)	2008-07-23	2015-10-06	Novartis Ag	Sphingosine 1 phosphate receptor modulators and their use to treat muscle inflammation
JP5731384B2 (ja) *	2008-08-18	2015-06-10	ノバルティスアーゲー	脱髄性末梢ニューロパシーの処置のためのアミノアルコール誘導体
CA2733508A1 (en) *	2008-08-18	2010-02-25	David Leppert	Compounds for the treatment of peripheral neuropathies
EP2177521A1 (en)	2008-10-14	2010-04-21	Almirall, S.A.	New 2-Amidothiadiazole Derivatives
ES2590904T3 (es)	2008-10-17	2016-11-24	Akaal Pharma Pty Ltd	Moduladores de receptores de S1P y uso de los mismos
CA2739901A1 (en)	2008-10-17	2010-04-22	Akaal Pharma Pty Ltd	S1p receptors modulators
EP2202232A1 (en)	2008-12-26	2010-06-30	Laboratorios Almirall, S.A.	1,2,4-oxadiazole derivatives and their therapeutic use
EP2210890A1 (en)	2009-01-19	2010-07-28	Almirall, S.A.	Oxadiazole derivatives as S1P1 receptor agonists
JP2012523458A (ja)	2009-04-13	2012-10-04	ザオハイオステートユニバーシティーリサーチファウンデーション	タンパク質ホスファターゼ２ａ活性化剤
AU2010236323A1 (en)	2009-04-17	2011-11-24	The Ohio State University Research Foundation	Antiadhesion agents
SI2467372T1 (sl)	2009-08-10	2016-09-30	Teva Pharmaceutical Industries Ltd.	Zdravljenje motenj, povezanih z BDNF, z uporabo lakvinimoda
EP2305660A1 (en)	2009-09-25	2011-04-06	Almirall, S.A.	New thiadiazole derivatives
EP2343287A1 (en)	2009-12-10	2011-07-13	Almirall, S.A.	New 2-aminothiadiazole derivatives
KR20160129093A (ko) *	2010-03-03	2016-11-08	테바 파마슈티컬 인더스트리즈 리미티드	라퀴니모드를 이용한 루푸스 신장염의 치료
EP2366702A1 (en)	2010-03-18	2011-09-21	Almirall, S.A.	New oxadiazole derivatives
EP2390252A1 (en)	2010-05-19	2011-11-30	Almirall, S.A.	New pyrazole derivatives
US8309768B2 (en)	2010-11-29	2012-11-13	The Ohio State University Research Foundation	FTY720-derived anticancer agents
WO2013055907A1 (en)	2011-10-12	2013-04-18	Teva Pharmaceutical Industries Ltd.	Treatment of multiple sclerosis with combination of laquinimod and fingolimod
BR112014018485A8 (pt)	2012-02-03	2017-07-11	Teva Pharma	Uso de laquinimod para tratar pacientes com a doença de crohn que falharam com a primeira linha de terapia anti-tnf
RU2482842C1 (ru) *	2012-04-26	2013-05-27	Открытое акционерное общество "Новосибхимфарм"	Фармацевтическая композиция агониста рецептора s1p для лечения демиелинизационных заболеваний (варианты) и способ ее получения
EP2708898A1 (de)	2012-09-14	2014-03-19	Sterna Biologicals GmbH & Co. Kg	Verfahren zur Diagnose eines molekularen Phänotyps eines an einer mit chronischen Entzündungen einhergehenden Erkrankung leidenden Patienten
AU2013341506A1 (en)	2012-11-07	2015-06-04	Teva Pharmaceutical Industries Ltd.	Amine salts of Laquinimod
SG11201506409RA (en)	2013-03-14	2015-09-29	Teva Pharma	Crystals of laquinimod sodium and improved process for the manufacture thereof
CN103992985A (zh) *	2014-05-09	2014-08-20	上海大学	神经鞘氨醇在中枢神经***中的作用
CN112237575A (zh) *	2020-11-09	2021-01-19	杭州端丽生物技术有限公司	芬戈莫德在防治鞘脂紊乱引起的神经退行性疾病中的医药用途
CN112924432A (zh) *	2021-04-08	2021-06-08	济宁市第一人民医院	一种血液真菌感染检测试剂盒及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5948820A (en) *	1994-08-22	1999-09-07	Yoshitomi Pharmaceutical Industries, Ltd.	Benzene compound and pharmaceutical use thereof
JPH1180026A (ja) *	1997-09-02	1999-03-23	Yoshitomi Pharmaceut Ind Ltd	新規免疫抑制剤、その使用方法およびその同定方法
EP1377554A1 (en) *	1999-06-16	2004-01-07	University Of Iowa Research Foundation	Antagonism of immunostimulatory cpg-oligonucleotides by 4-aminoquinolines and other weak bases
KR20080103117A (ko) *	2002-09-24	2008-11-26	노파르티스 아게	탈수초성 장애의 치료에 있어서의 스핑고신-1-포스페이트 수용체 아고니스트
EP1663188B1 (en) *	2003-09-12	2016-08-10	Newron Sweden AB	Treatment of disorders of the nervous system
EP2392320A1 (en) *	2006-08-17	2011-12-07	University Of Chicago	Treatment of inflammatory diseases

2007
- 2007-08-17 EP EP11170326A patent/EP2392320A1/en not_active Withdrawn
- 2007-08-17 CN CN201210024062.7A patent/CN102526736B/zh not_active Expired - Fee Related
- 2007-08-17 US US12/377,736 patent/US8258150B2/en not_active Expired - Fee Related
- 2007-08-17 CA CA2660880A patent/CA2660880C/en not_active Expired - Fee Related
- 2007-08-17 CN CN2007800344676A patent/CN101553216B/zh not_active Expired - Fee Related
- 2007-08-17 MX MX2009001788A patent/MX2009001788A/es active IP Right Grant
- 2007-08-17 WO PCT/US2007/018331 patent/WO2008021532A2/en active Application Filing
- 2007-08-17 ES ES07837041T patent/ES2393631T3/es active Active
- 2007-08-17 RU RU2009109418/15A patent/RU2440110C2/ru not_active IP Right Cessation
- 2007-08-17 BR BRPI0715950-1A2A patent/BRPI0715950A2/pt not_active IP Right Cessation
- 2007-08-17 SI SI200731077T patent/SI2056807T1/sl unknown
- 2007-08-17 PT PT78370418T patent/PT2056807E/pt unknown
- 2007-08-17 PL PL07837041T patent/PL2056807T3/pl unknown
- 2007-08-17 DK DK07837041.8T patent/DK2056807T3/da active
- 2007-08-17 EP EP07837041A patent/EP2056807B1/en active Active
- 2007-08-17 JP JP2009524698A patent/JP5216769B2/ja not_active Expired - Fee Related
- 2007-08-17 AU AU2007284337A patent/AU2007284337B2/en not_active Ceased
2009
- 2009-10-19 HK HK09109655.8A patent/HK1131047A1/xx not_active IP Right Cessation
2012
- 2012-08-06 US US13/567,590 patent/US9101576B2/en not_active Expired - Fee Related
- 2012-12-14 HR HRP20121034TT patent/HRP20121034T1/hr unknown
2013
- 2013-03-04 JP JP2013041387A patent/JP2013144694A/ja active Pending
2015
- 2015-08-05 US US14/818,534 patent/US9370497B2/en not_active Expired - Fee Related
- 2015-08-17 JP JP2015160277A patent/JP2015221824A/ja active Pending

Also Published As

Publication number	Publication date
EP2392320A1 (en)	2011-12-07
JP2013144694A (ja)	2013-07-25
RU2440110C2 (ru)	2012-01-20
US20130017190A1 (en)	2013-01-17
ES2393631T3 (es)	2012-12-26
CA2660880C (en)	2015-10-13
JP5216769B2 (ja)	2013-06-19
HRP20121034T1 (hr)	2013-01-31
JP2015221824A (ja)	2015-12-10
WO2008021532A2 (en)	2008-02-21
HK1131047A1 (en)	2010-01-15
MX2009001788A (es)	2009-09-23
CN101553216A (zh)	2009-10-07
AU2007284337B2 (en)	2012-07-19
US9101576B2 (en)	2015-08-11
PL2056807T3 (pl)	2013-02-28
CN102526736B (zh)	2016-01-20
US20150335666A1 (en)	2015-11-26
US8258150B2 (en)	2012-09-04
RU2009109418A (ru)	2010-09-27
AU2007284337A1 (en)	2008-02-21
SI2056807T1 (sl)	2012-12-31
CN102526736A (zh)	2012-07-04
EP2056807B1 (en)	2012-09-26
JP2010500995A (ja)	2010-01-14
US20100310547A1 (en)	2010-12-09
CA2660880A1 (en)	2008-02-21
CN101553216B (zh)	2012-03-21
EP2056807A2 (en)	2009-05-13
BRPI0715950A2 (pt)	2013-07-30
WO2008021532A3 (en)	2008-05-29
PT2056807E (pt)	2012-12-21
US9370497B2 (en)	2016-06-21

Publication	Publication Date	Title
DK2056807T3 (da)	2012-10-22	Behandling af inflammatoriske sygdomme
DK1874781T3 (da)	2009-11-02	Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
DK2004204T3 (da)	2013-01-07	Behandling af neurodegenerative sygdomme med selenat
DK2474321T3 (da)	2019-06-03	Sammensætninger til behandling af collagenmedierede sygdomme
DK2120977T3 (da)	2013-08-12	Behandling af inflammatoriske sygdomme under anvendelse af placenta-stamceller
DK3456707T3 (da)	2020-07-20	4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
DK1986633T3 (da)	2014-11-03	Behandling af duchennes muskeldystrofi
DK1856975T3 (da)	2014-05-12	Behandling af havebrugsafgrøder
DK2222272T3 (da)	2013-02-11	Behandling af luftvejssygdom
DK2700786T3 (da)	2019-01-02	Modifikation af overførselspassage
DK2056842T3 (da)	2013-01-14	Modificeret galactosylceramid til behandling af cancerøse sygdomme
DK1962869T3 (da)	2013-06-24	Behandling af luftvejssygdomme
DK2035369T3 (da)	2014-10-06	Terapeutiske
DK2285808T3 (da)	2014-02-03	Spiroindolderivater til behandling af parasitsygdomme
DK2111555T3 (da)	2013-09-02	Diagnosticering af præeklampsi
DK2107870T3 (da)	2016-04-11	Lavement med reduceret irritationseffekt til behandling af inflammatorisk tarmsygdom
DK2099446T3 (da)	2013-02-11	Fremgangsmåde til behandling af inflammatorisk tarmsygdom
DK2117565T3 (da)	2012-11-19	Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
DK2056858T3 (da)	2014-09-29	Behandling af lungesygdomstilstande
DK2022504T3 (da)	2013-02-11	Salve til behandling af hæmorider
GB0700972D0 (en)	2007-02-28	Treatment of inflammatory disease
FI20065834A0 (fi)	2006-12-21	Iskulaite
LTPA2016019I1 (lt)	2016-06-27	Išsėtinės sklerozės (MS) gydymas kampatu-1H
DK2175849T3 (da)	2013-05-13	Behandling af melanomer
ES1064635Y (es)	2007-07-01	Disposicion de conjuntos conmutadores de pulsador